Q&A With Gilmore O'Neill of Biogen International: Tecfidera as MS Treatment Leader

Chronic conditions like multiple sclerosis require constant monitoring by doctors and patients, As time goes on medication and treatment options may need to be changed. Tecfidera, one popular treatment option has become a popular choice in patient care.

Gilmore O'Neill, MD, of Biogen International discussed what has made the medication a go to choice for doctors and patients alike during the American Academy of Neurology's annual meeeting in Washington, DC. O'Neill also discussed the safety profile for the medication and the advantages of Tecfidera being an oral treatment option.